Prophylactic zalcitabine and interferon-alpha for a large-bore needlestick exposure to human immunodeficiency virus.
Mildvan
D
D
Bergé
P
P
Starrett
S
S
St Clair
M
M
Salgo
M
M
D000328:Adult; D016049:Didanosine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016602:Needlestick Injuries / Q000150:complications*; D011994:Recombinant Proteins; D016047:Zalcitabine / Q000494:pharmacology / Q000627:therapeutic use*; D015215:Zidovudine / Q000494:pharmacology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine